Health Technology Assessment

This blog contains a selection of the posters and presentations given by OHE at ISPOR Philadelphia in May 2015.

This mapping of priority-setting considers factors such as existence of HTA institutions and commitment to UHC (Brazil, Chile, Colombia, Mexico, Uruguay, Ghana, Kenya, Malawi, South Africa, Uganda, China, India, Indonesia, Myanmar, Philippines, Thailand and Vietnam).

Articles co-authored by Adrian Towse, Martina Garau, Donna Messner, and Penny Mohr exploring future expectations of drug relative effectiveness in Europe and comparative effectiveness in the USA just published online.

Dr Steven Pearson has convened a US policy workgroup of payers, drug and device manufacturers, patients' groups, and clinician specialty societies to help develop a “value framework”.

OHE has published an Occasional Paper highlighting the significant shortage of data that forced Claxton et al. to rely on a large number of strong assumptions to produce their results.

Dr. Aslam Anis, Director of the Centre for Health Evaluation and Outcomes Sciences (CHEOS) in Canada will undertake a short sabbatical with the Office of Health Economics in February 2015.

Jon Sussex presents on the opportunity costs of implementing NICE decisions in Wales, and OHE attend HESG in Leeds, January 2015.

For information on OHE at ISPOR Europe please see earlier posts: OHE at ISPOR Europe 1 and...

On 18th November 2014 OHE’s Professor Nancy Devlin presented at the King’s Fund Patient-reported outcome measures (PROMs) research conference. Nancy’s presentation focused on the role of the EQ-VAS.

Just published in Social Science & Medicine [open access] is a social preference study by OHE’s Koonal Shah and the University of Sheffield’s Aki Tsuchiya and Allan Wailoo. The study examines the extent of societal support for ...


Subscribe to RSS - Health Technology Assessment